IP Library Assignment 068963/0047
Patent Assignment
Reel/Frame 068963/0047

Change of Name

Recorded: 2024-09-16 Pages: 6
Assignor
ZYNERBA PHARMACEUTICALS, INC.
Executed: 2024-07-01
Assignee
HARMONY BIOSCIENCES MANAGEMENT, INC.
630 W. GERMANTON PIKE, SUITE 215, PLYMOUTH MEETING, PENNSYLVANIA, 19462
Covered Property (1)
Treatment of Fragile X Syndrome with Cannabidiol
Application: 18/458,727 →
Publication: US 2023/0414533
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 16, 2024
From: BONN-MILLER, MARCEL; TICH, NANCY; GUTTERMAN, DONNA; MESSENHEIMER, JOHN
To: ZYNERBA PHARMACEUTICALS, INC.
Reel/Frame 068597/0362 →
Supplemental Confirmatory Grant of Security Interest in United States Patents May 18, 2026
From: HARMONY BIOSCIENCES MANAGEMENT, INC. (F/K/A ZYNERBA PHARMACEUTICALS, INC.)
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 075642/0639 →